Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> MELANOMA Latest News

9 HOURS AGO - Health Canal

A Must Read - Share

New ‘linchpin’ in melanoma survival

The lethal double-life of a protein known as RIP1 has been exposed by University of Newcastle cancer researcher Professor Xu Dong Zhang, potentially spurring an all-new generation of highly targeted and long-lasting drugs for melanoma.

Tags: New ‘linchpin’ in melanoma survival,  Melanoma Latest News

MAR 25, 2015 - Fox News

A Must Read - Share

Merck says melanoma drug meets goal; study halted

Merck & Co Inc said on Tuesday that it would stop a large study of its Keytruda melanoma treatment early because an independent monitoring committee determined the drug succeeded in its goal of prolonging survival in previously untreated patients at advanced stage of the disease.

Tags: Merck says melanoma drug meets goal; study halted,  Melanoma Latest News

MAR 25, 2015 - Health Canal

A Must Read - Share

Gene faults increase melanoma risk

Scientists at the QIMR Berghofer Medical Research Institute have identified two new gene faults which dramatically increase the risk of melanoma.

Tags: Gene faults increase melanoma risk,  Melanoma Latest News

MAR 24, 2015 - Health Canal

A Must Read - Share

Radiation Plus Immunotherapy Combination Improves Immune System Response to Metastatic Melanoma

A triple attack of radiation plus two immunotherapies appears to improve the immune system response in patients with metastatic melanoma, according to a recent study from a multidisciplinary team of researchers, including the Miller School’s Hemant Ishwaran, Ph.D., professor of public health sciences.

Tags: Radiation Plus Immunotherapy Combination Improves Immune System Response to Metastatic Melanoma,  Melanoma Latest News

MAR 24, 2015 - Yahoo! News

A Must Read - Share

Study of Merck melanoma drug halted after survival prolonged

(Reuters) - Merck & Co Inc said on Tuesday a large study of its Keytruda melanoma treatment will be stopped early because an independent monitoring committee determined the drug succeeded in its goal of prolonging survival in previously untreated patients with advanced melanoma. The medicine, a so-called PD-1 inhibitor that works by taking the brakes off the immune system, is ...

Tags: Study of Merck melanoma drug halted after survival prolonged,  Melanoma Latest News